Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shoshana Barnoy

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Vaccine|May 21, 2013
Evaluation of virulent and live Shigella sonnei vaccine candidates in a gnotobiotic piglet modelKwang-Il Jeong, Malabi M Venkatesan, Shoshana Barnoy, et al.
Plos One|January 17, 2024
B memory cell responses to LPS, IVP and IpaB antigen after oral vaccination with Shigella sonnei vaccine candidates WRSs2 and WRSs3Malabi M Venkatesan, Shoshana Barnoy, Robert Frenck, et al.
FEMS Immunology and Medical Microbiology|July 29, 2006
Developing live Shigella vaccines using lambda Red recombineeringRyan T Ranallo, Shoshana Barnoy, Sejal Thakkar, et al.
Gut Microbes|March 10, 2017
The Galleria mellonella larvae as an in vivo model for evaluation of Shigella virulenceShoshana Barnoy, Hanan Gancz, Yuewei Zhu, et al.
Plos One|November 18, 2021
Antibody in Lymphocyte Supernatant (ALS) responses after oral vaccination with live Shigella sonnei vaccine candidates WRSs2 and WRSs3 and correlation with serum antibodies, ASCs, fecal IgA and sheddingMalabi M Venkatesan, Cassandra Ballou, Shoshana Barnoy, et al.
Comparative Medicine|October 2, 2009
Safety and colonization of two novel VirG(IcsA)-based live Shigella sonnei vaccine strains in rhesus macaques (Macaca mulatta)Todd A Collins, Shoshana Barnoy, Shahida Baqar, et al.
Frontiers in Microbiology|September 23, 2024
A rhesus macaque intragastric challenge model for evaluating the safety, immunogenicity, and efficacy of live-attenuated <i>Shigella dysenteriae</i> 1 vaccine candidatesNattaya Ruamsap, Rawiwan Imerbsin, Patchariya Khanijou, et al.
Biochemistry|September 11, 2002
Role for phospholipid interactions in the trafficking defect of Delta F508-CFTROfer Eidelman, Shoshana BarNoy, Michal Razin, et al.
Gut Microbes|October 11, 2011
Further characterization of Shigella sonnei live vaccine candidates WRSs2 and WRSs3-plasmid composition, invasion assays and Sereny reactionsLisa Bedford, Suramya Fonseka, Tara Boren, et al.
Vaccine|February 13, 2025
BECC-engineered live-attenuated Shigella vaccine candidates display reduced endotoxicity with robust immunogenicity in miceMatthew E Sherman, Jane Michalski, Sayan Das, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Vaccine|May 21, 2013
Evaluation of virulent and live Shigella sonnei vaccine candidates in a gnotobiotic piglet modelKwang-Il Jeong, Malabi M Venkatesan, Shoshana Barnoy, et al.
Plos One|January 17, 2024
B memory cell responses to LPS, IVP and IpaB antigen after oral vaccination with Shigella sonnei vaccine candidates WRSs2 and WRSs3Malabi M Venkatesan, Shoshana Barnoy, Robert Frenck, et al.
FEMS Immunology and Medical Microbiology|July 29, 2006
Developing live Shigella vaccines using lambda Red recombineeringRyan T Ranallo, Shoshana Barnoy, Sejal Thakkar, et al.
Gut Microbes|March 10, 2017
The Galleria mellonella larvae as an in vivo model for evaluation of Shigella virulenceShoshana Barnoy, Hanan Gancz, Yuewei Zhu, et al.
Plos One|November 18, 2021
Antibody in Lymphocyte Supernatant (ALS) responses after oral vaccination with live Shigella sonnei vaccine candidates WRSs2 and WRSs3 and correlation with serum antibodies, ASCs, fecal IgA and sheddingMalabi M Venkatesan, Cassandra Ballou, Shoshana Barnoy, et al.
Comparative Medicine|October 2, 2009
Safety and colonization of two novel VirG(IcsA)-based live Shigella sonnei vaccine strains in rhesus macaques (Macaca mulatta)Todd A Collins, Shoshana Barnoy, Shahida Baqar, et al.
Frontiers in Microbiology|September 23, 2024
A rhesus macaque intragastric challenge model for evaluating the safety, immunogenicity, and efficacy of live-attenuated <i>Shigella dysenteriae</i> 1 vaccine candidatesNattaya Ruamsap, Rawiwan Imerbsin, Patchariya Khanijou, et al.
Biochemistry|September 11, 2002
Role for phospholipid interactions in the trafficking defect of Delta F508-CFTROfer Eidelman, Shoshana BarNoy, Michal Razin, et al.
Gut Microbes|October 11, 2011
Further characterization of Shigella sonnei live vaccine candidates WRSs2 and WRSs3-plasmid composition, invasion assays and Sereny reactionsLisa Bedford, Suramya Fonseka, Tara Boren, et al.
Vaccine|February 13, 2025
BECC-engineered live-attenuated Shigella vaccine candidates display reduced endotoxicity with robust immunogenicity in miceMatthew E Sherman, Jane Michalski, Sayan Das, et al.
Pageof 2